Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Key Points: Sickle cell patients show mitochondrial dysfunction (complex V inhibition, oxidant formation), which is associated with platelet activation. Complex V inhibition is induced by hemolysis and causes platelet activation, which is attenuated by mitochondrial therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders · doi:10.1002/mds.23148 · Cited by 606
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391 · cited 5×
“This rotenoneinsensitive OCR was completely inhibited by allopurinol (100 mM) and indomethacin (100 mM; data not shown), consistent with prior reports of increased activity of oxygen-consuming enzymes in SCD.28When normalized for differences in nonmitochondrial OCR, platelets fromSCDpatients showed a significantly low…”
BackgroundInfluentialVillagra, J., Shiva, S., Hunter, L. A., Machado, R. F., Gladwin, M. T., & Kato, G. J. (2007) · Blood · doi:10.1182/blood-2006-12-061697 · Cited by 384 · cited 5×
“Prior studies have focused on the role of hemoglobin-mediated NO scavenging in hemolysis-induced platelet activation.(15) However, it is conceivable that in the presence of superoxide generated by free hemoglobin, NO could be oxidized to yield species such as nitrogen dioxide (NO2 ) and peroxynitrite (ONOO) that media…”
BackgroundMethodInfluentialSelf-citationBosetti, F. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00314-1 · Cited by 348
Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298
Research works printed but not linked: 35
- Schapira, 1998, Mitochondria in the etiology and pathogenesis of Parkinson’s disease., Ann Neurol, 44, S89, 10.1002/ana.410440714 · DOI · Paper page
- Sjövall, 2010, Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis., Crit Care, 14, R214, 10.1186/cc9337 · DOI
- Lorente, 2012, Survival and mitochondrial function in septic patients according to mitochondrial DNA haplogroup., Crit Care, 16, R10, 10.1186/cc11150 · DOI
- Avila, 2012, Platelet mitochondrial dysfunction is evident in type 2 diabetes in association with modifications of mitochondrial anti-oxidant stress proteins., Exp Clin Endocrinol Diabetes, 120, 248, 10.1055/s-0031-1285833 · DOI
- Guo, 2009, Platelets of type 2 diabetic patients are characterized by high ATP content and low mitochondrial membrane potential., Platelets, 20, 588, 10.3109/09537100903288422 · DOI
- Holmsen, 1969, Adenine nucleotide metabolism of blood platelets. V. Subcellular localization of some related enzymes., Biochim Biophys Acta, 186, 244, 10.1016/0005-2787(69)90002-1 · doi:10.1016/0005-2787(69)90002-1
- Salganicoff, 1972, Energy metabolism of blood platelets. I. Isolation and properties of platelet mitochondria., Arch Biochem Biophys, 153, 726, 10.1016/0003-9861(72)90391-8 · DOI
- Jobe, 2008, Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis., Blood, 111, 1257, 10.1182/blood-2007-05-092684 · DOI · Paper page
- Matarrese, 2009, Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A—activation and long-term commitment to cell death., FEBS J, 276, 845, 10.1111/j.1742-4658.2008.06829.x · DOI
- Yamagishi, 2001, Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction., Diabetes, 50, 1491, 10.2337/diabetes.50.6.1491 · DOI · Paper page
- Blann, 2003, Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity., Blood Coagul Fibrinolysis, 14, 255, 10.1097/01.mbc.0000061293.28953.8c · DOI
- Tomer, 2001, Thrombogenesis in sickle cell disease., J Lab Clin Med, 137, 398, 10.1067/mlc.2001.115450 · DOI · Paper page
- Wun, 1998, Platelet activation in patients with sickle cell disease., Br J Haematol, 100, 741, 10.1046/j.1365-2141.1998.00627.x · DOI · Paper page
- Antonucci, 1990, Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets., Am J Hematol, 34, 44, 10.1002/ajh.2830340110 · DOI
- Brittain, 1993, Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion., Blood, 81, 2137, 10.1182/blood.V81.8.2137.2137 · DOI · Paper page
- Ross, 1974, A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro., Proc Natl Acad Sci USA, 71, 1207, 10.1073/pnas.71.4.1207 · DOI · Paper page
- Yu, 2012, Mitochondria in vascular disease., Cardiovasc Res, 95, 173, 10.1093/cvr/cvs111 · DOI · Paper page
- Dromparis, 2010, The role of mitochondria in pulmonary vascular remodeling., J Mol Med (Berl), 88, 1003, 10.1007/s00109-010-0670-x · DOI
- Chacko, 2013, Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood., Lab Invest, 93, 690, 10.1038/labinvest.2013.53 · DOI · Paper page
- Fink, 2012, Endothelial cell and platelet bioenergetics: effect of glucose and nutrient composition., PLoS ONE, 7, e39430, 10.1371/journal.pone.0039430 · DOI
- Walkowiak, 1997, Microplate reader—a convenient tool in studies of blood coagulation., Thromb Res, 87, 95, 10.1016/S0049-3848(97)00108-4 · doi:10.1016/s0049-3848(97)00108-4
- Shiva, 2011, The detection of the nitrite reductase and NO-generating properties of haemoglobin by mitochondrial inhibition., Cardiovasc Res, 89, 566, 10.1093/cvr/cvq327 · DOI · Paper page
- Minneci, 2008, Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis., Am J Physiol Heart Circ Physiol, 295, H743, 10.1152/ajpheart.00151.2008 · DOI · Paper page
- Wun, 1997, Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia., J Lab Clin Med, 129, 507, 10.1016/S0022-2143(97)90005-6 · DOI · Paper page
- Wun, 2013, A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease., 17
- Dromparis, 2013, Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension., Circ Res, 113, 126, 10.1161/CIRCRESAHA.112.300699 · DOI · Paper page
- Kaul, 2013, Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications., Am J Physiol Heart Circ Physiol, 304, H42, 10.1152/ajpheart.00296.2012 · DOI
- Patel, 2008, Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha., Blood, 112, 856, 10.1182/blood-2007-12-130567 · DOI
- Bonnet, 2006, An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension., Circulation, 113, 2630, 10.1161/CIRCULATIONAHA.105.609008 · DOI · Paper page
- Kane, 2009, Post-translational modifications of ATP synthase in the heart: biology and function., J Bioenerg Biomembr, 41, 145, 10.1007/s10863-009-9218-6 · DOI
- Wang, 2013, Redox regulation of mitochondrial ATP synthase., Trends Cardiovasc Med, 23, 14, 10.1016/j.tcm.2012.08.005 · DOI
- Hebbel, 1985, Auto-oxidation and a membrane-associated ‘Fenton reagent’: a possible explanation for development of membrane lesions in sickle erythrocytes., Clin Haematol, 14, 129, 10.1016/S0308-2261(21)00465-3 · DOI
- Dayal, 2013, Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis., Circulation, 127, 1308, 10.1161/CIRCULATIONAHA.112.000966 · DOI · Paper page
- Pignatelli, 1998, Hydrogen peroxide is involved in collagen-induced platelet activation., Blood, 91, 484, 10.1182/blood.V91.2.484 · DOI · Paper page
- Choo, 2012, Mitochondrial calcium and reactive oxygen species regulate agonist-initiated platelet phosphatidylserine exposure., Arterioscler Thromb Vasc Biol, 32, 2946, 10.1161/ATVBAHA.112.300433 · DOI
Cited by
Nolfi-Donegan, D., Braganza, A., & Shiva, S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101674 · Cited by 1,488
Self-citationPathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationIntravascular hemolysis and the pathophysiology of sickle cell disease
Kato, G. J., Steinberg, M. H., & Gladwin, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89741 · Cited by 748
Cardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
Bennewitz, M. F., Jimenez, M. A., Vats, R., Tutuncuoglu, E., Jonassaint, J., Kato, G. J., Gladwin, M. T., & Sundd, P. (2017) · JCI Insight · doi:10.1172/jci.insight.89761 · Cited by 139
“Several recent studies using humanized SCD mice and blood samples from SCD patients have established that cell-free hemoglobin and heme released into the circulation during hemolysis serve to activate neutrophils, platelets, and the endothelium by scavenging NO and activating the TLR4 pathway, respectively (4, 23, 30,…”
Background
Metadata
- Authors
- Cardenes, N., Corey, C., Geary, L., Jain, S., Zharikov, S., Barge, S., Novelli, E. M., & Shiva, S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2014-05-01
- Volume
- 123
- Issue
- 18
- Pages
- 2864-2872
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1980850191
- Cited by
- 150
- References
- 13
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation. https://app.cochat.ai/papers/10.1182/blood-2013-09-529420
- The paper
- Cardenes, N., Corey, C., Geary, L., Jain, S., Zharikov, S., Barge, S., Novelli, E. M., & Shiva, S. (2014). Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation. Blood. https://doi.org/10.1182/blood-2013-09-529420
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.